 | • レポートコード：MRC2304D088 • 出版社/出版日：Transparency Market Research / 2023年1月26日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、遺伝子合成の世界市場を分析し、市場実態を明らかにしています。本書は、エグゼクティブサマリー、市場概要、市場リスク＆動向分析、市場背景、主な成功要因、需要分析＆予測、市場規模分析＆予測、手法別（固相合成、チップベース合成、PCRベース酵素合成）分析、サービス種類別（抗体DNA合成、ウイルスDNA合成、その他）分析、用途別（遺伝子＆細胞治療開発、ワクチン開発、疾病診断、その他）分析、エンドユーザー別（バイオ＆医薬品会社、学術＆政府研究機関、受託研究機関）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析などを収録しています。また、GenScript、Brooks Automation, Inc. (GENEWIZ)、Boster Biological Technology、Twist Bioscience、ProteoGenix、Biomatik、ProMab Biotechnologies, Inc.、Thermo Fisher Scientific, Inc.、Integrated DNA Technologies, Inc.、OriGene Technologies, Inc.などの企業情報を掲載しています。 ・エグゼクティブサマリー ・市場概要 ・市場リスク＆動向分析 ・市場背景 ・主な成功要因 ・需要分析＆予測 ・市場規模分析＆予測 ・世界の遺伝子合成市場規模：手法別 - 固相合成の市場規模 - チップベース合成の市場規模 - PCRベース酵素合成の市場規模 ・世界の遺伝子合成市場規模：サービス種類別 - 抗体DNA合成サービスの市場規模 - ウイルスDNA合成サービスの市場規模 - その他サービスの市場規模 ・世界の遺伝子合成市場規模：用途別 - 遺伝子＆細胞治療開発における市場規模 - ワクチン開発における市場規模 - 疾病診断における市場規模 - その他用途における市場規模 ・世界の遺伝子合成市場規模：エンドユーザー別 - バイオ＆医薬品会社における市場規模 - 学術＆政府研究機関における市場規模 - 受託研究機関における市場規模 ・世界の遺伝子合成市場規模：地域別 - 北米の遺伝子合成市場規模 - 中南米の遺伝子合成市場規模 - ヨーロッパの遺伝子合成市場規模 - アジア太平洋の遺伝子合成市場規模 - 中東・アフリカの遺伝子合成市場規模 ・市場構造分析 ・競争分析 |
Gene Synthesis Market – Scope of Report
TMR’s report on the global gene synthesis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global gene synthesis market for the period 2017–2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gene synthesis market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the gene synthesis market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gene synthesis market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global gene synthesis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gene synthesis market.
The report delves into the competitive landscape of the global gene synthesis market. Key players operating in the global gene synthesis market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global gene synthesis market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market gene synthesis.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Gene Synthesis
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Gene Synthesis Market, by Key Countries
4.2. Gene Synthesis Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Gene Synthesis Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Gene Synthesis Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Gene Synthesis Market Demand Analysis 2018-2022 and Forecast, 2023-2033
6.1. Historical Market Analysis, 2018-2022
6.2. Current and Future Market Projections, 2023-2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Gene Synthesis Market Value Analysis 2018-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Method
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Method, 2018-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method, 2023-2033
8.3.1. Solid-phase Synthesis
8.3.2. Chip-based Synsthesis
8.3.3. PCR-based Enzyme Synthesis
8.4. Market Attractiveness Analysis By Method
9. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Service Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Service Type, 2018-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Service Type, 2023-2033
9.3.1. Antibody DNA Synthesis
9.3.2. Viral DNA Synthesis
9.3.3. Other Service Types
9.4. Market Attractiveness Analysis By Service Type
10. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2018-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023-2033
10.3.1. Gene & Cell Therapy Development
10.3.2. Vaccine Development
10.3.3. Disease Diagnosis
10.3.4. Others
10.4. Market Attractiveness Analysis By Application
11. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By End-User
11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End-User, 2018-2022
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2023-2033
11.3.1. Biotechnology & Pharmaceutical Companies
11.3.2. Academic & Government Research Institutes
11.3.3. Contract Research Organization
11.4. Market Attractiveness Analysis By End-User
12. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2023-2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Method
13.4.3. By Service Type
13.4.4. By End-User
13.4.5. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Method
13.5.3. By Service Type
13.5.4. By End-User
13.5.5. By Application
14. Latin America Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Method
14.4.3. By Service Type
14.4.4. By End-User
14.4.5. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Method
14.5.3. By Service Type
14.5.4. By End-User
14.5.5. By Application
15. Europe Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Method
15.4.3. By Service Type
15.4.4. By End-User
15.4.5. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Method
15.5.3. By Service Type
15.5.4. By End-User
15.5.5. By Application
16. Asia Pacific Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Method
16.4.3. By Service Type
16.4.4. By End-User
16.4.5. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Method
16.5.3. By Service Type
16.5.4. By End-User
16.5.5. By Application
17. Middle East and Africa Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Method
17.4.3. By Service Type
17.4.4. By End-User
17.4.5. By Application
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Method
17.5.3. By Service Type
17.5.4. By End-User
17.5.5. By Application
18. Key Countries Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Gene Synthesis Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.2.2.1. By Method
18.2.2.2. By Service Type
18.2.2.3. By End-User
18.2.2.4. By Application
18.3. Canada Gene Synthesis Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.3.2.1. By Method
18.3.2.2. By Service Type
18.3.2.3. By End-User
18.3.2.4. By Application
18.4. Mexico Gene Synthesis Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.4.2.1. By Method
18.4.2.2. By Service Type
18.4.2.3. By End-User
18.4.2.4. By Application
18.5. Brazil Gene Synthesis Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.5.2.1. By Method
18.5.2.2. By Service Type
18.5.2.3. By End-User
18.5.2.4. By Application
18.6. Germany Gene Synthesis Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.6.2.1. By Method
18.6.2.2. By Service Type
18.6.2.3. By End-User
18.6.2.4. By Application
18.7. France Gene Synthesis Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.7.2.1. By Method
18.7.2.2. By Service Type
18.7.2.3. By End-User
18.7.2.4. By Application
18.8. Italy Gene Synthesis Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.8.2.1. By Method
18.8.2.2. By Service Type
18.8.2.3. By End-User
18.8.2.4. By Application
18.9. BENELUX Gene Synthesis Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.9.2.1. By Method
18.9.2.2. By Service Type
18.9.2.3. By End-User
18.9.2.4. By Application
18.10. UK Gene Synthesis Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.10.2.1. By Method
18.10.2.2. By Service Type
18.10.2.3. By End-User
18.10.2.4. By Application
18.11. Nordic Countries Gene Synthesis Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.11.2.1. By Method
18.11.2.2. By Service Type
18.11.2.3. By End-User
18.11.2.4. By Application
18.12. China Gene Synthesis Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.12.2.1. By Method
18.12.2.2. By Service Type
18.12.2.3. By End-User
18.12.2.4. By Application
18.13. Japan Gene Synthesis Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.13.2.1. By Method
18.13.2.2. By Service Type
18.13.2.3. By End-User
18.13.2.4. By Application
18.14. South Korea Gene Synthesis Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.14.2.1. By Method
18.14.2.2. By Service Type
18.14.2.3. By End-User
18.14.2.4. By Application
18.15. GCC Countries Gene Synthesis Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.15.2.1. By Method
18.15.2.2. By Service Type
18.15.2.3. By End-User
18.15.2.4. By Application
18.16. South Africa Gene Synthesis Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.16.2.1. By Method
18.16.2.2. By Service Type
18.16.2.3. By End-User
18.16.2.4. By Application
18.17. Turkey Gene Synthesis Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
18.17.2.1. By Method
18.17.2.2. By Service Type
18.17.2.3. By End-User
18.17.2.4. By Application
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. GenScript
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Brooks Automation, Inc. (GENEWIZ)
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Boster Biological Technology
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Twist Bioscience
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. ProteoGenix
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Biomatik
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. ProMab Biotechnologies, Inc.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Thermo Fisher Scientific, Inc.
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Integrated DNA Technologies, Inc.
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. OriGene Technologies, Inc.
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology